US authorises new antibody drug 'Eli Lilly' to fight Omicron variant
World | February 13, 2022 8:37 ISTThe FDA announcement comes after the two leading monoclonal antibody treatments in the U.S. turned out to be ineffective against omicron. Data indicate the Lilly drug also works against the emerging BA.2 mutation of omicron.